BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16038031)

  • 1. Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line.
    Gao XQ; Han JX; Huang HY; Song B; Zhu B; Song CZ
    World J Gastroenterol; 2005 Jul; 11(28):4337-43. PubMed ID: 16038031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray.
    Gao XQ; Han JX; Huang HY; Yan S; Song CZ; Huang HN
    Acta Pharmacol Sin; 2004 Oct; 25(10):1327-33. PubMed ID: 15456535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
    Galamb O; Spisák S; Sipos F; Tóth K; Solymosi N; Wichmann B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Br J Cancer; 2010 Feb; 102(4):765-73. PubMed ID: 20087348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
    Li M; Wu X; Xu XC
    Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells.
    Pan MR; Chang HC; Chuang LY; Hung WC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):456-62. PubMed ID: 18367635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
    Li M; Wu X; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
    Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
    Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].
    Huang DS; Xu X; Zheng SS; Cheng JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonsteroidal anti-inflammatory drug NS398 regulates the RECK gene expression in the prostate carcinoma strain DU145].
    Xu ZY; Gao JP; Sun YH; Zhang ZY; Ge JP; Xu CL; Wang LH
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):303-6. PubMed ID: 18481419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis.
    Che SM; Zhang XZ; Hou L; Song TB
    Cancer Invest; 2010 Aug; 28(7):679-88. PubMed ID: 20486853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of NS398 on the proliferation of human ovarian cancer cell lines CAOV3 and OVCAR3 in vitro].
    Wang CY; Wang M; Wang XY; Zhang SL; Wang YX; Li LK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):415-8. PubMed ID: 12921553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells.
    Kim SJ; Seo JH; Lee YJ; Yoon JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Oncology; 2005; 68(2-3):204-11. PubMed ID: 16015035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells.
    Huang RH; Chai J; Tarnawski AS
    World J Gastroenterol; 2006 Oct; 12(40):6446-52. PubMed ID: 17072976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of cyclooxygenase-2 inhibitor in inhibition of proliferation of colon cancer cells by modulating Stat5 signal transduction pathway].
    Ma XT; Yu LW; Wang S; Zhang H; Du RY; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2566-9. PubMed ID: 16321305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.